Stockreport

Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results

Telesis Bio, Inc.  (TBIO) 
PDF SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeuti [Read more]